Abstracts

IMMUNE RESPONSES AFTER ChAdOx1 OR BNT162b2 BOOSTERS IN PRIMARY CORONAVAC VACCINATION

Inactivated SARS-CoV-2 vaccine (CoronaVac) is commonly used in national immunization programmes. However, an immune response of CoronaVac significantly declined after 3 months, our study, thus, aimed to explore the immune response against COVID-19 following the booster dose by assessing both B-cell and T-cell activities compared to the convalescent samples. In this prospective cohort study, 98…

DURABILITY AND BOOSTABILITY OF Ad26.COV2.S IN RHESUS MACAQUES

Ad26.COV2.S is a single-shot vaccine that has demonstrated clinical efficacy against symptomatic COVID-19. In this study, we report the durability of immune responses in 20 rhesus macaques received single-shot Ad26.COV2.S and the immunogenicity of a booster shot at 8-10 months following the initial immunization. Animals were immunized by intramuscular route with 10[sup]11[/sup] vp (N=10) or…

S mRNA PRIME S+N DNA BOOST VACCINATION ELICITS ROBUST IMMUNE RESPONSES IN MICE

Currently available COVID-19 vaccination regimens in the US deliver either a homologous spike (S) mRNA prime-boost or a prime-only S DNA adenovirus-vectored antigen to elicit humoral and cell-mediated responses to confer protection against SAR-CoV-2 infection. Alternatively, heterologous vaccination using two different platforms has the potential to enhance and expand immune protection. Addition of a second…

PROTECTIVE EFFICACY OF A GASTROINTESTINAL SARS-CoV-2 VACCINE

SARS-CoV-2 remains a global threat, despite the rapid deployment but limited coverage of multiple vaccines. Alternative vaccine strategies that have favorable manufacturing timelines, greater ease of distribution and improved coverage may offer significant public health benefits, especially in resource-limited settings. Live oral vaccines have the potential to address some of these limitations; however no studies…

ARMY LIPOSOMAL SPIKE FERRITIN NANOPARTICLE VACCINE INDUCES DURABLE IMMUNE RESPONSES

Immunization strategies that rapidly modulate appropriate and precise interactions between the innate and adaptive immune responses are essential to generate robust, durable, and protective immunity against pathogens. Here, we describe a novel vaccine platform, Spike Ferritin Protein Nanoparticle (SpFN) mixed with the adjuvant Army Liposome Formulation containing QS-21 (ALFQ) and assessed the vaccine-induced immune signatures.…

SPIKE PLUS NUCLEOCAPSID VACCINE PROTECTS AGAINST SARS-CoV-2 DELTA INFECTION IN NHPs

SARS-CoV-2 vaccines capable of inducing broad and cross-reactive humoral and T cell responses help to fight against emerging variants. In this study we compared the immunogenicity and efficacy of modified vaccinia Ankara (MVA) based SARS-CoV-2 vaccine expressing furin-cleavage site inactivated stabilized spike (SdFCS) and nucleocapsid (N) delivered via intramuscular (IM), buccal or sublingual (SL) routes…

INVESTIGATING CONSERVED SEQUENCE IN THE SARS-CoV-2 GENOME AS NOVEL VACCINE IMMUNOGEN

It is imperative to investigate novel, broadly conserved coronavirus immunogens as new SARS-CoV-2 variants of concern are continually emerging. The goal of this study was to generate a broadly protective long-term vaccine candidate against potential new variants of SARS-CoV-2 and novel, outbreak coronaviruses. The vaccine immunogen spanned portions of the highly conserved RNA replication machinery…